CD74 primarily promotes tumour progression through its signalling function, making it a potential tumour marker or targeted drug target [28] Due to the absence of targeted inhibitors for CD74, the MIF inhibitor ISO‐1 was chosen to inhibit CD74 function by occupying the binding domain of MIF. The gene discussed is CD74; the disease is neoplasm.